Migraine and genetic polymorphisms: An overview

Open Neurology Journal

Volumn 6, Issue 1, 2012, Pages 65-70

  Pizza, Vincenzo ^a   Agresta, Anella ^a   Agresta, Antonio ^a   Lamaida, Eros ^a   Lamaida, Norman ^a   Infante, Francesco ^a   Capasso, Anna ^b  

^a Vallo della Lucania SA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Genetic polymorphisms; Migraine; Thrombosis; Vascular disease

Indexed keywords

APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; FIBRINOGEN B BETA CHAIN; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; RIBOFLAVIN; UNCLASSIFIED DRUG;

BRAIN BLOOD FLOW; ENERGY METABOLISM; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MIGRAINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 84866138843     PISSN: None     EISSN: 1874205X     Source Type: Journal    
DOI: 10.2174/1874205X01206010065     Document Type: Review

References (36)

1. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene C677T influences susceptibility to migraine with aura. BMC Med 2004; 2: 3-7.
2. Chiodini BD, Barlera S, Franzosi MG, Rognoni G. I geni di suscettibilità all'infarto: una revisione della letteratura. Ital Heart J 2001; 2: 935-944.
3. C Colucci D'Amato V, Alfano E, Giordano T, Marmolo V. Pizza: Le Cefalee, Napoli: Idelson 1997, p.129.
4. Bianchi A, Pitari GM, Amenta V, et al. Endothelial, Haemostatic and haemorheological modifications in migraineurs; Artery 1996; 22: 93-100.
5. Corral J, Iniesta JA, Gonzà-Conejero R, Lozano ML, Rivera J, Vicente V. Migraine and prothrombotic genetic risk factors. Cephalalgia 1998; 18: 257.
6. Colson NJ, Fernandez F, Griffiths LR. Migraine genetics and prospects for pharmacotherapy. Drug Dev Res 2007; 68: 282-93.
7. Kowa H, Fusayasu E, Ijiri I, et al. Association of the Insertion/Deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 2005; 374: 129-31.
8. Paterna S, Di Pasquale P, D'Angelo A, et al. Angiotensin -converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000; 43: 133-43
9. Lin JJ, Wang PJ, Chen CH, et al. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan 2005; 14: 120-5.
10. Lea RA, Ovcaric M, Sundholm J, Solyom L, MacMillan J, Griffiths LR. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 2005; 136: 112-7.
11. Iniesta JA, Corral J, Gonzà-Conejero R, et al. Role of factor XIII (Val 34 Leu) polymorphism in patients with migraine. Cephalalgia 2001; 8: 837-41.
12. Rainero I, Grimaldi LM, Salani G, et al. Apolipoprotein E gene polymorphism in patients with migraine; Neurosci Lett 2002; 317: 111: 3.
13. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Neuropsychiatric Genet; 2000; 96: 762-4.
14. Kara I, Sazei A, Ergul E, Kaya G, Kilie G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahy-drofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003; 111: 84-90.
15. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 1938; 39: 737-63.
16. Wolff HG. Headache and Other Head Pain. 2nd ed. New York: Oxford University Press 1963.
17. Campbell JK, Caselli RJ. Headache and other craniofacial pain. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, Eds. Neurology Clinical Prac 1991; 2: 1525-6. Butterworth-Heinemann, Boston.
18. Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 1993; 13: 395-399.
19. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 16: 157-68.
20. Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 1993; 5: 159-77.
21. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
22. Gemmati D. Le nuove mutazioni: Haemostasis e Thrombosis. Biochim Clin 2002; 26 (3): 135
23. Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study. J Intern Med 1999; 242: 339-47.
24. Bostom AG, Silbershatz H, Rosenberg IH. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 1999; 24: 1077-80.
25. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotidartery stenosis. New Engl J Med 1995; 332: 286-91.
26. Perry IJ. Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middleaged British men. Lancet 1995; 346: 1395-8.
27. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
28. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000; 96: 762-4.
29. Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sala, B. Is blood hmocysteine elevated in migraine? Headache 2001; 41: 779-81.
30. Wolff PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotidartery stenosis. New Engl J Med 1995; 332: 286-91
31. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 2006; 26: 361-72.
32. Finnilä S, Hassinen IE, Majamaa K. Phylogenetic analysis of mitochondrial DNA in patients with an occipital stroke. Evaluation of mutations by using sequence data on the entire coding region. Mutat Res 2001; 458: 31-9.
33. Hansrote S, Croul S, Selak M, Kalman B, Schwartzmann RJ. External ophtalmologia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation. J Neurol Sci 2002; 197: 63-7
34. Pietrobon D. Calcium channel and channelopathies of the central nervous system. Mol Neurobiol 2002; 25: 31-50
35. Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 2009; 29: 719-28.
36. Di Lorenzo C, Pierelli F, Coppola G, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology 2009; 72: 1588-94.